Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2R,3R,4R,5S)-5-((R)-2-amino-1-(((2R,3R,4R)-3,4-dihydroxy-6-(((3S,7R)-7-methyl-2-oxoazepan-3-yl)carbamoyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-oxoethyl)-2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxytetrahydrofuran-3-yl pentadecanoate
ID: ALA5284944
Max Phase: Preclinical
Molecular Formula: C39H61N5O13
Molecular Weight: 807.94
Associated Items:
This compound is not in our inventory system